Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Camille Dabrowski"'
Autor:
Nathalie Labarrière, Sylvain Simon, Virginie Vignard, Tiffany Beauvais, Valentin Voillet, Camille Dabrowski, Nicolas Jouand, Amir Khammari, Cécile Braudeau, Régis Josien, Caroline Laheurte, François Aubin, Charles Nardin, Samuel Rulli, Raphael Gottardo, Candice D Church
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Clinical benefit from programmed cell death 1 receptor (PD-1) inhibitors relies on reinvigoration of endogenous antitumor immunity. Nonetheless, robust immunological markers, based on circulating immune cell subsets associated with therape
Externí odkaz:
https://doaj.org/article/e9c7452d81254d408bd2276450f26642
Autor:
Valentin Voillet, Tiffany Beauvais, Brigitte Dréno, Charles Nardin, Régis Josien, Camille Dabrowski, Nathalie Labarrière, Stanley R. Riddell, Sylvain Simon, Candice D. Church, Nicolas Jouand, Raphael Gottardo, Olivier Adotevi, Amir Khammari, François Aubin, Steven P. Fling, Cécile Braudeau, Martin A. Cheever, Virginie Vignard, Paul Nghiem, Samuel Rulli, Nirasha Ramchurren, Caroline Laheurte, Zhong Wu
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer, BMJ Publishing Group 2020, 8, pp.e001631. ⟨10.1136/jitc-2020-001631⟩
Journal for Immunotherapy of Cancer, 2020, 8, pp.e001631. ⟨10.1136/jitc-2020-001631⟩
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer, BMJ Publishing Group 2020, 8, pp.e001631. ⟨10.1136/jitc-2020-001631⟩
Journal for Immunotherapy of Cancer, 2020, 8, pp.e001631. ⟨10.1136/jitc-2020-001631⟩
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
BackgroundClinical benefit from programmed cell death 1 receptor (PD-1) inhibitors relies on reinvigoration of endogenous antitumor immunity. Nonetheless, robust immunological markers, based on circulating immune cell subsets associated with therapeu
Autor:
Stanley R. Riddell, Régis Josien, Camille Dabrowski, Olivier Adotevi, Virginie Vignard, Nathalie Labarrière, Raphael Gottardo, Amir Khammari, Tiffany Beauvais, Valentin Voillet, Cécile Braudeau, Steven P. Fling, Nirasha Ramchurren, Charles Nardin, Cheever Martin, Samuel Rulli, Brigitte Dréno, Paul Nghiem, Zhong Wu, Caroline Laheurte, Francçois Aubin, Nicolas Jouand, Sylvain Simon, Candice D. Church
Publikováno v:
Cancer Research. 80:4476-4476
Immunotherapies targeting the PD-1 pathway have profoundly transformed the clinical care of cancer patients for a growing variety of cancer types. However, most patients do not experience durable clinical benefit. The definition of robust and conveni